HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of recombinant factor VIIa for hip replacement surgery in a patient with severe factor XI deficiency and drug-induced platelet defect.

AuthorsC-E Dempfle, T Frietsch, T Hoffmann, P Ahmad-Nejad, M Neumaier, M Borggrefe
JournalHaemophilia : the official journal of the World Federation of Hemophilia (Haemophilia) Vol. 14 Issue 5 Pg. 1147-9 (Sep 2008) ISSN: 1365-2516 [Electronic] England
PMID18582229 (Publication Type: Case Reports, Letter)
Chemical References
  • Recombinant Proteins
  • recombinant FVIIa
  • Factor VIIa
Topics
  • Aged, 80 and over
  • Arthroplasty, Replacement, Hip
  • Blood Loss, Surgical (prevention & control)
  • Blood Platelet Disorders (complications)
  • Factor VIIa (therapeutic use)
  • Factor XI Deficiency (complications)
  • Female
  • Hemostasis, Surgical (methods)
  • Humans
  • Recombinant Proteins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: